UBS Group’s STAAR Surgical STAA Stock Holding History

UBS Group’s Portfolio STAA Stock Details STAA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.81M	Hold	63,000	–	–	﹤0.01%	5196
2026 Q1	$1.18M	Buy	+63,000	New	+$1.2M	﹤0.01%	5426

Other funds holding STAA

Broadwood Capital New York $1.91B AUM 44.39% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return

Yunqi Capital Hong Kong $125M AUM 13.99% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AIM

Anatole Investment Management Central, Hong Kong $590M AUM 751.98% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

UBS Group's STAA Position: Q2 2026 in Review

UBS Group increased its STAAR Surgical (STAA) stake by 90% in Q2 2026, buying an estimated $4.48M and bringing the position to 341,183 shares worth $9.79M. The position accounts for ﹤0.01% of the portfolio, ranked #3484.

UBS Group first reported a position in STAA in Q4 2014 and has held it in 47 quarters since. 200 funds tracked by Wall St. Rank hold STAA as of Q2 2026.

UBS Group held 341,183 shares of STAAR Surgical worth $9.79M as of Q2 2026.
UBS Group bought 161,254 STAAR Surgical shares in Q2 2026, an estimated $4.48M.
STAAR Surgical made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #3484 holding.
UBS Group first reported a position in STAAR Surgical in Q4 2014 and has held it in 47 quarters since.
200 funds tracked by Wall St. Rank held STAAR Surgical as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.